Integration of interferon-α/β signalling to p53 responses in tumour suppression and antiviral defence
The DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.
Abstract
Swift elimination of undesirable cells is an important feature in tumour suppression and immunity. The tumour suppressor p53 and interferon-alpha and -beta (IFN-alpha/beta) are essential for the induction of apoptosis in cancerous cells and in antiviral immune responses, respectively, but little is known about their interrelationship. Here we show that transcription of the p53 gene is induced by IFN-alpha/beta, accompanied by an increase in p53 protein level. IFN-alpha/beta signalling itself does not activate p53; rather, it contributes to boosting p53 responses to stress signals. We show examples in which p53 gene induction by IFN-alpha/beta contributes to tumour suppression. Furthermore, we show that p53 is activated in virally infected cells to evoke an apoptotic response and that p53 is critical for antiviral defence of the host. Our study reveals a hitherto unrecognized link between p53 and IFN-alpha/beta in tumour suppression and antiviral immunity, which may have therapeutic implications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In response to senesce-inducing stimuli, senescent cells produce, in a cGAS-dependent manner, type I interferons that have pro-senescence and anti-proliferative activities.”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [273]
In the citing paper
“Indeed, β-interferons increase ROS production, leading to DNA damage and p53 activation [273,274].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [273]
Citations
Cites
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080 · cited 1×
“2a ); ISRE is activated by the IFN-activated transcription factor ISGF3, a heterotrimeric complex consisting of a signal transducer and activator of transcription factor 1 (Stat1), Stat2 and interferon regulatory factor 9 (IRF-9”
BackgroundMice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649 · cited 1×
“Previous studies have shown that p53 -deficient mice show no sign of abnormality in T and B cells, and that they can mount adaptive immune responses normall”
ResultMdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506 · cited 1×
“We performed a pulse–chase experiment to examine whether the observed p53 protein induction is secondary to suppression of the p53 degradation pathway by IFN-β, typically the MDM2-mediated pathwa”
MethodPapillomaviruses and cancer: from basic studies to clinical application
zur Hausen, H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc798 · Cited by 4,024 · cited 1×
“Persistent infection with oncogenic HPV types represents a major risk factor for the development of cervical cancer, in which E6 is known to have a critical role (together with another oncoprotein, E7 (ref”
BackgroundDNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
Bakkenist, C. J., & Kastan, M. B. (2003) · Nature · doi:10.1038/nature01368 · Cited by 3,466 · cited 1×
“We infer that, similar to DNA damage, ATM activation is caused by changes in the chromatin structure in virus-infected cell”
BackgroundRegulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 1×
“We performed a pulse–chase experiment to examine whether the observed p53 protein induction is secondary to suppression of the p53 degradation pathway by IFN-β, typically the MDM2-mediated pathwa”
MethodLive or let die: the cell's response to p53
Vousden, K. H., & Lu, X. (2002) · Nature Reviews Cancer · doi:10.1038/nrc864 · Cited by 3,192
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
Lowe, S. W., Ruley, H. E., Jacks, T., & Housman, D. E. (1993) · Cell · doi:10.1016/0092-8674(93)90719-7 · Cited by 2,925 · cited 1×
“We also examined the effect of IFN-β on the DNA damage-induced apoptotic response of MEFs expressing the adenovirus E1A oncoprotein, as it is well known that this response is p53-dependent and critical for tumour suppressio”
BackgroundNoxa, a BH3-Only Member of the Bcl-2 Family and Candidate Mediator of p53-Induced Apoptosis
Oda, E., Ohki, R., Murasawa, H., Nemoto, J., Shibue, T., Yamashita, T., Tokino, T., Taniguchi, T., & Tanaka, †. N. (2000) · Science · doi:10.1126/science.288.5468.1053 · Cited by 2,112
Self-citation
Research works printed but not linked: 1
- Vilcek, J. & Sen, G. S. in Fields Virology 3rd edn (eds Fields, D. M., Knipe, P. M. & Howley, P. M.) 375–399 (Lippincott-Raven, Philadelphia, 1996)
Cited by
Items 701–800 of 867
Immunosurveillance: Innate and Adaptive Antitumor Immunity
Jinushi, M., & Dranoff, G. (2007) · Elsevier eBooks · doi:10.1016/b978-012372551-6/50067-5 · Cited by 4
Kim, T., Hong, S., Song, K., Park, S., & Shin, Y. K. (2017) · Oncotarget · doi:10.18632/oncotarget.14573 · Cited by 5
Hayashi, T., Miyagawa, Y., Tsujimura, A., Nonomura, N., Minami, M., & Okuyama, Ä. (2006) · International Journal of Urology · doi:10.1111/j.1442-2042.2006.01408.x · Cited by 4
Rath, P. C. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2005.05.003 · Cited by 4
Voelter‐Mahlknecht, S., Mahlknecht, U., Letzel, S., & Fierlbeck, G. (2006) · SKINmed Dermatology for the Clinician · doi:10.1111/j.1540-9740.2006.05678.x · Cited by 4
Zhao, H., Ma, J., Wang, Y., Liu, J., Shao, Y., Li, J., Jiang, G., & Xing, M. (2017) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2017.07.017 · Cited by 4
“344 As a downstream transcriptional target of type I interferon signaling (Takaoka et al., 2003), p53 345 transcriptionally regulates the expression of interferon regulatory factor (IRF) 5 and IRF9, and is 346 induced in response to viral infections (Rivas et al., 2010), indicating a positive…”
BackgroundIntegrating gene therapy into the treatment paradigm for non-muscle invasive bladder cancer
Steinmetz, A. R., Jazayeri, B., Pierce, M., Mokkapati, S., McConkey, D. J., Li, R., & Dinney, C. P. (2025) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2024.2445674 · Cited by 3
TUSCAN: Tumor segmentation and classification analysis in spatial transcriptomics
Zang, C., Guo, C. C., Wang, Y., Wei, P., & Li, Z. G. (2026) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1014058 · Cited by 3
Recent progress in cGAS–STING agonist design and mechanisms of cancer immune modulation
Wang, L., Nafees, M., Fei, H., Hanif, M., & Yang, P. (2026) · RSC Chemical Biology · doi:10.1039/d6cb00005c · Cited by 3
Gjoerup, O. V. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0016-5_14 · Cited by 4
Domingues, A. C. M., de Oliveira, S. B., Tessarollo, N. G., Lepique, A. P., Rodrigues, O. A., Sharova, T. Y., Lawless, A. R., Li, D., Basnet, M., Boland, G. M., et al. (2025) · Molecular Therapy Oncology · doi:10.1016/j.omton.2025.200942 · Cited by 9
Katamura, Y., Aikata, H., Kimura, Y., Azakami, T., Kawaoka, T., Takaki, S., Waki, K., Hiramatsu, A., Kawakami, Y., Takahashi, S., et al. (2009) · Hepatology Research · doi:10.1111/j.1872-034x.2008.00448.x · Cited by 3
Setthawongsin, C., Tangkawattana, S., Rungsipipat, A., & Techangamsuwan, S. (2019) · Frontiers in Veterinary Science · doi:10.3389/fvets.2019.00104 · Cited by 3
Regulating cellular plasticity to persist: a way for tumor viruses to triumph
Yılmaz, V., & Strati, K. (2019) · Current Opinion in Virology · doi:10.1016/j.coviro.2019.06.007 · Cited by 3
Artificial Life and Therapeutic Vaccines Against Cancers that Originate in Viruses
Escobar-Ospina, M. E., & Gómez, J. (2019) · Springer eBooks · doi:10.1007/978-3-030-29022-1_8 · Cited by 3
Oncolytic Viruses as Immunotherapeutic Agents
Trehub, Y., & Havrilov, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-50287-4_27 · Cited by 4
Active constituents of herbal medicines for breast cancer: Current status
Kumar, S., Mazhar, M., Jogpal, V., Yadav, S., Jarag, R. J., Bhatt, S., & Patil, C. R. (2023) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2023.87630 · Cited by 3
“apoptosis) and Bax if DNA repair fails (Takaoka et al., 2003).”
Integration of the DNA Damage Response with Innate Immune Pathways
Gordon, M., & Gasser, S. (2011) · InTech eBooks · doi:10.5772/24735 · Cited by 3
“In support of this idea, p53-deficient mice show higher viral titer and mortality after vesicular stomatitis virus infection (Takaoka et al., 2003).”
InfluentialOsawa, H., Mizuno, M., Hatano, M., Nakahara, N., Tsuno, T., Kuno, T., Endo, M., & Yoshida, J. (2005) · Cytokine · doi:10.1016/j.cyto.2005.10.003 · Cited by 3
Yao, Y., Kubota, T., Sato, K., Takeuchi, H., Handa, Y., & Matsukawa, S. (2005) · Journal of Neuro-Oncology · doi:10.1007/s11060-005-6498-5 · Cited by 3
Nakamoto, M., Shuto, E., Hosaka, T., & Sakai, T. (2010) · European Journal of Nutrition · doi:10.1007/s00394-010-0153-4 · Cited by 3
Novel and Unexpected Role for the Tumor Suppressor ARF in Viral Infection Surveillance
García, M. Á., Muñoz‐Fontela, C., Collado, M., Marcos-Villar, L., Estéban, M., & Rivas, C. (2007) · Future Virology · doi:10.2217/17460794.2.6.625 · Cited by 3
“Intriguingly, some of these IFN-regulated genes have also been implicated in tumorprotective networks [1–6].”
BackgroundKim, J., Yu, K. N., Noh, M. S., Woo, M., Park, S. J., Park, J., Jin, H., Cho, H. S., Hwang, S. K., Lee, E.-S., et al. (2008) · Journal of Veterinary Science · doi:10.4142/jvs.2008.9.1.45 · Cited by 3
“[7] demonstrated that transcription of the p53 gene was induced by IFN-α, accompanied by an increase in p53 protein levels and they provided examples in which p53 gene induction by IFN-α indeed contributed to tumor suppression.”
BackgroundPri-miR-34b/c rs4938723 Polymorphism Contributes to Coronary Artery Disease Susceptibility
Cen, J.-M., Xiong, Q., Yang, X.-L., Guo, J., Xiong, X., & Zhang, A. (2019) · Archives of Medical Research · doi:10.1016/j.arcmed.2019.07.009 · Cited by 5
Gupta, S. K., Chaubey, K. K., Khandelwal, V., Sharma, T., & Singh, S. V. (2021) · Springer eBooks · doi:10.1007/978-981-16-0045-6_24 · Cited by 3
Cho, H., Lee, J., Lawler, S. E., & Kim, Y. (2026) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1013906 · Cited by 2
Multifaceted Antiviral Actions of Interferon-stimulated Gene Products
Strobl, B., Leitner, N. R., & Müller, M. M. (2012) · Springer eBooks · doi:10.1007/978-3-7091-0891-8_21 · Cited by 2
Basal Level p53 Suppresses Antiviral Immunity Against Foot-And-Mouth Disease Virus
Zhang, T., Chen, H.-T., Liu, X., Qi, L., Gao, X., Wang, K., Yao, K., Zhang, J., Sun, Y., Zhang, Y., et al. (2019) · Viruses · doi:10.3390/v11080727 · Cited by 2
Li, J., Xu, J., Wang, Y., Li, Q., Sun, X., Fu, W., & Zhang, B. (2022) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2021.0181 · Cited by 2
“In addition, studies have demonstrated that p53 is essential for host antiviral innate immune responses and is associated with the replication of some viruses (Takaoka et al. , 2003; Pang et al. , 2011). p53 is involved in several CHB infection strategies.”
Hu, X., Chen, J., Dai, W., Xiao, Y., Chen, X., Chen, Z., Zhang, S., & Hu, Y. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05279-z · Cited by 2
“Inflammatory factors induced by viral infection (such as interferons and TNF-α) can further promote P53 activa - tion and expression [ 37 , 38 ].”
BackgroundLee, D., Oh, S., Lawler, S. E., & Kim, Y. (2025) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2025028 · Cited by 2
Type I interferon system and IRF family of transcription factors in host defense regulation
Taniguchi, T., & Takaoka, A. (2005) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.81.1 · Cited by 3
Self-citationCutaneous T-cell lymphoma: Biologic targets for therapy
Choi, J., & Foss, F. M. (2007) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-007-0037-8 · Cited by 2
Characterization of Treatment Response to Recombinant Interferon-a2b in Osteosarcoma Xenografts
Müller, C. R., Namløs, H. M., Bjerner, J., Østensen, I. H. G., & Sæter, G. (2010) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.1000018 · Cited by 4
Yata, Y., Kanda, D., Hatanaka, T., Iesaki, K., Yoshinaga, T., & Higuchi, T. (2010) · Kanzo · doi:10.2957/kanzo.51.565 · Cited by 2
Interferon and Apoptosis in Systemic Lupus Erythematosus
Daniel, N., & Brian, D. (2012) · InTech eBooks · doi:10.5772/25734 · Cited by 4
Yang, S., Kawamura, K., Okamoto, S., Yamauchi, S., Shingyoji, M., Sekine, I., Kobayashi, H., Tada, Y., Tatsumi, K., Hiroshima, K., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1482-8 · Cited by 2
“Regulation of the p53 pathways after Ad infection is controlled even by a host defense system such as interferons [27].”
BackgroundThe Bi-directional Nature of the Promoter of the p53 Tumor Suppressor Gene
Amanda, D., & Zeigler, P. (2015) · Journal of Leukemia · doi:10.4172/2329-6917.1000187 · Cited by 3
Microarray Analysis of Human Vascular Smooth Muscle Cell Responses to Bacterial Lipopolysaccharide
., J., Minta, J. O., Yun, J. J., Der, S., & Rana, S. (2007) · American Journal of Immunology · doi:10.3844/ajisp.2007.56.73 · Cited by 2
HOST CELL FUNCTIONS IN VESICULAR STOMATITIS VIRUS REPLICATION
Dinh, P. X., Das, A., & Pattnaik, A. K. (2014) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814635349_0006 · Cited by 2
Vieira, I. D. L., Tamura, R. E., Hunger, A., & Strauss, B. E. (2019) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2018.0124 · Cited by 2
p19Arf sensitizes B16 melanoma cells to interferon-β delivered via mesenchymal stem cells in vitro
Da-Costa, R. C., Vieira, I. L., Hunger, A., Tamura, R. E., & Strauss, B. E. (2020) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20198876 · Cited by 2
“The type I interferon and p53/ p19Arf pathways are known to cooperate in the induction of anti-viral defense and cell death (16,17).”
BackgroundSarabandi, S., Karami, S., Heravi, M., Tabasi, F., Hashemi, M. M., & Bahari, G. (2020) · Meta Gene · doi:10.1016/j.mgene.2020.100760 · Cited by 2
An Overview of Innate Immune Response to Human Rhinovirus Infection
Hudu, S. A. (2021) · Journal of Molecular Virology and Immunology · doi:10.46683/jmvi.2021.34 · Cited by 2
Hosonaga, M., Habano, E., Arakawa, H., Kaneko, K., Nakajima, T., Hayashi, N., Fukada, I., Nakamura, A., Haruyama, Y., Maeda, T., et al. (2024) · Breast Cancer · doi:10.1007/s12282-024-01612-3 · Cited by 3
Hußner, J., Sünwoldt, J., Seibert, I., Gliesche, D. G., & zu Schwabedissen, H. E. M. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.05.020 · Cited by 1
New Insights in Photoaging Process Revealed by In Vitro Reconstructed Skin Models
Marionnet, C., Duval, C., & Bernerd, F. (2016) · Springer eBooks · doi:10.1007/978-3-662-47398-6_163 · Cited by 1
Chudhary, H. R. F., Ali, A., Bibi, S., Waqas, M. S., Rafique, S., Idrees, M., Halim, S. A., Abdellattif, M. H., Khan, A., & Al‐Harrasi, A. (2023) · ACS Omega · doi:10.1021/acsomega.3c00903 · Cited by 1
Song, W., Toh, J., Chen, S., Xing, R., & Li, D. (2024) · Biomaterials Science · doi:10.1039/d4bm01283f · Cited by 1
Biotechnology, beginning with recombinant DNA toward a personalized medicine
García, N. V. (2009) · Orinoquia · doi:10.22579/20112629.237 · Cited by 1
“…the production of recombinant interferon (rIFN) with today’s more than ten products in the market place (among them are INFERGEN, AVONEX), rIFN has been widely used to treat cancer, autoimmune disorders included multiple sclerosis and viral infections (Nagata et al., 1980; Takaoka et al., 2003).”
BackgroundNarayan, V., Meek, S. E. M., & Ball, K. L. (2010) · Molecular biology intelligence unit · doi:10.1007/978-1-4419-8231-5_12 · Cited by 1
Hepatitis B infection in Malta : a retrospective cross sectional study
Vella, R., Spiteri, D. B., Farrugia, A., Caruana, N., & Pocock, J. (2012) · OAR@UM (University of Malta) · Cited by 1
Interleukin-1 Superfamily and Cancer
Yuzhalin, A. E., & Kutikhin, A. G. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801121-8.00002-6 · Cited by 2
Degrave, W. M. S., & Mendonça-Lima, L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-444-63660-7.00003-6 · Cited by 1
Ikushima, H., Yanai, H., & Taniguchi, T. (2015) · Springer eBooks · doi:10.1007/978-4-431-55327-4_7 · Cited by 1
Self-citationMultiple Routes for Survival: Understanding How Cancer Evades Apoptosis
Xu, Y., Cui, J., & Puett, D. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1381-7_7 · Cited by 1
Relationship between Helicobacter pylori detection and an increased risk of infection in childhood
Venerando, R., Rasmussen, L., de Lábio, R. W., Gatti, L. L., Francisco, O., Viani, G., Rivera, L., & Payão, S. L. M. (2012) · The Journal of venomous animals and toxins including tropical diseases · doi:10.1590/s1678-91992012000400004 · Cited by 1
Scorched Earth or Viral Birth?
Gentle, I. E., & Nachbur, U. (2011) · The Open Cell Signaling Journal · doi:10.2174/1876390101103010035 · Cited by 1
Inducible cAMP early repressor (ICER) is a novel regulator of RIG-I mediated IFN-β production
Johnsen, I. B., Bergstrøm, B., Stiberg, K. A. H., Thommesen, L., & Anthonsen, M. W. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.05.014 · Cited by 1
New Insights in Photoaging Process Revealed by In Vitro Reconstructed Skin Models
Marionnet, C., Duval, C., & Bernerd, F. (2015) · Springer eBooks · doi:10.1007/978-3-642-27814-3_163-1 · Cited by 3
Type I Interferons: History and Perspectives as Immunotherapeutic Agents Against Cancer
Gorgulho, C. M., Romagnoli, G. G., & Kaneno, R. (2020) · Springer eBooks · doi:10.1007/978-3-030-50287-4_11 · Cited by 1
Cytokine Receptors and Signaling
Khan, M. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-30273-7_3 · Cited by 2
Future Application of Oncolytic Viruses for Cancer Treatment
Lesmana, J. A., & Jo, J. (2023) · Medicinus · doi:10.19166/med.v10i3.7037 · Cited by 1
Xia, Y., Yang, Y. T., Liu, Y., Cheng, J., Liu, Y., Li, C., & Liu, P. (2024) · Marine Biotechnology · doi:10.1007/s10126-024-10296-x · Cited by 1
“TP53 plays a central role in the response to environmental damage, promoting cell survival or apoptosis in zebrafish (Takaoka et al. 2003).”
Yamaguchi, T., Kadoya, S., Ishibayashi, K., Asakawa, T., Gunjigake, K., Ohbatake, Y., Terai, S., Kitamura, H., Bando, H., & Inaki, N. (2025) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2025.102172 · Cited by 1
Genetically engineered biomaterials
Withanage, S. (2020) · Figshare · doi:10.6084/m9.figshare.12129522 · Cited by 1
Hochrein, H., & Wagner, H. (2006) · Wiley eBooks · doi:10.1002/9783527619696.ch7 · Cited by 1
Vaccinia virus modulates the host cell cycle to promote infection
Martin, C. K. (2019) · UCL Discovery (University College London) · Cited by 1
Accurately estimating pathway activity in single cells for clustering and differential analysisPreprint
Davis, D., Wizel, A., & Drier, Y. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.27.534310 · Cited by 1
TRIM22/Staf50 - a novel target gene of the tumor suppressor p53
Obad, S. (2007) · Lund University Publications (Lund University) · Cited by 1
Katsushima, S., 武史, 中., Sumida, Y., 斉祐, 田., 達郎, 小., 紀滋, 鍋., 岡野, 明., Sando, T., 俊彦, 川., 藤村和代, et al. (2014) · Kanzo · doi:10.2957/kanzo.55.335
Understanding KSHV vIRF-2-cell interactions
Mutocheluh, M. (2011) · University of Birmingham Institutional Research Archive (University of Birmingham)
Multiple Sclerosis: Studies of the Interferon system and search for infectious agents
Bergkvist, M. (2005) · Lund University Publications (Lund University)
The effects of host response and vaccine design on early signaling profiles of MUC1-specific T cells
Reichenbach, D. K. (2013) · D-Scholarship@Pitt (University of Pittsburgh)
On the function of the interferon-inducible p53 target gene TRIM22
Petersson, J. (2011) · Lund University Publications (Lund University)
Waddell, P. J., & Herston, T. (2009) · arXiv (Cornell University) · doi:10.48550/arxiv.0912.5315
Hino, K., Tomiyama, Yoshioka, Yanai, Kawase, Nishina, Hara, Yoshida, Korenaga, & Korenaga (2011) · Hepatic Medicine Evidence and Research · doi:10.2147/hmer.s19695
Minton, K. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1176
Construção de ferramentas para estudo da possível interação entre interferon-beta e p53.
Melo, V. A. M. R. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.87.2009.tde-17082009-121304
“Então, a indução de p53 por IFNβ é causada por ativação transcricional (TAKAOKA et al., 2003).”
BackgroundInfluentialOuboussad, L. (2009) · OpenGrey (Institut de l'Information Scientifique et Technique)
Molecular Mechanisms of Reovirus Oncolysis
Pan, D. (2013) · Library and Archives Canada (Government of Canada)
Adjuvant Therapy After Radiofrequency Ablation
Gao, H., & Chen, M. (2015) · Springer eBooks · doi:10.1007/978-94-017-7258-7_10
Davis, C. (2016) · uO Research (University of Ottawa) · doi:10.20381/ruor-813
Moran, T. P. (2006) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/8hh8-s166
Influence of Synthetic Oestrogens on the Synthesis of Interferon-γ in Human Leukocytes
Davitashvili, M. D., & Natsvlishvili, N. K. (2015) · Russian Journal of Biological Research · doi:10.13187/ejbr.2015.3.12
Chaves, M. A. G., & Chaves, G. (2016) · Anales de la Real Academia Nacional de Farmacia · Cited by 1
Role of interferons and immunotherapy in enhancing radiation treatment of cancer
Lim, J., & Lord, E. M. (2014) · UR Research (University of Rochester)
The role of interleukin-31 in human allergic disease
Stott, B. (2012) · Spiral (Imperial College London) · doi:10.25560/12871
Novel Strategies in Chemotherapy for Gliomas
Natsume, A., Chalise, L., & Wakabayashi, T. (2015) · Japanese Journal of Neurosurgery · doi:10.7887/jcns.24.386
Lysko, M. D. (2016) · TSpace (University of Toronto)
Ataç, B. (2008) · IYTE GCRIS Database (Izmir Institute of Technology) · Cited by 1
ZNF313 is a novel cell cycle activator with an E3 ligase activity inhibiting cellular senescence by
Han, J., Yl, K., Lee, K.-W., Her, N.-G., Ha, T.-K., Yoon, S., Jeong, S.-I., Lee, J., Kang, M. J., Lee, M., et al. (2013)
Role of IRF6 in Notch regulated apoptosis, cell cycle and differentiation in breast epithelial cells
Ekinci, B. (2015) · IYTE GCRIS Database (Izmir Institute of Technology)
The Antiviral Properties of Melaleuca alternifolia concentrate (MAC) against West Nile virus
Zamora, A. C. P. (2015) · Griffith Research Online · doi:10.25904/1912/2151
Uchiumi, F., Arakawa, J., Takihara, Y., Akui, M., Hamada, H., & Tanuma, S. (2018) · InTech eBooks · doi:10.5772/intechopen.71095 · Cited by 1
Targeting Canonical and Noncanonical Hedgehog Signaling Pathways in Cancer
Larsen, A. R. (2014)
Regulation of promyelocytic leukemia protein expression
Dobrovolná, J. (2008) · Digital Repository (National Repository of Grey Literature)
Metadata
- Authors
- Takaoka, A., Hayakawa, S., Yanai, H., Stoiber, D., Negishi, H., Kikuchi, H., Sasaki, S., Imai, K., Shibue, T., Honda, K., & Taniguchi, T.
- Affiliations
- The University of Tokyo (JP)
- University of Vienna (AT)
- Sapporo Medical University (JP)
- Corresponding author
- Taniguchi, Tadatsugu
- ORCID
- Venue
- Nature
- Published
- 2003-07
- Volume
- 424
- Issue
- 6948
- Pages
- 516-523
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2119885778
- Cited by
- 847
- References
- 51
- Citations by year
- 2026: 13 · 2025: 18 · 2024: 20 · 2023: 25 · 2022: 22 · 2021: 32 · 2020: 41 · 2019: 40 · 2018: 21 · 2017: 38 · 2016: 50 · 2015: 44 · 2014: 40 · 2013: 46 · 2012: 38
- FWCI
- 20.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Boehringer Ingelheim Japan
- Senri Life Science Foundation
- Kanae Foundation for the Promotion of Medical Science
- Japan Society for the Promotion of Science
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- p53, type I interferon, interferon signaling, tumor suppression, antiviral defense, apoptosis, viral infection, cancer therapy
- MeSH terms
- Animals, Cell Transformation, Neoplastic, DNA-Binding Proteins, Humans, Mice, Inbred C57BL, Neoplasms, RNA, Messenger, Transcription Factors, Transcription, Genetic, Tumor Cells, Cultured, Vesicular stomatitis Indiana virus, Signal Transduction, Transcriptional Activation, Gene Expression Regulation, Neoplastic, Tumor Suppressor Protein p53, Interferon-alpha, Interferon-beta, Apoptosis, Response Elements, Interferon-Stimulated Gene Factor 3, Interferon-Stimulated Gene Factor 3, gamma Subunit, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.